US Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

US Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-144	Closed	-$14K	–	620
2015 Q4	$14K	Hold	144	–	–	0.01%	284
2015 Q3	$13K	Hold	144	–	–	0.02%	243
2015 Q2	$15K	Hold	144	–	–	0.01%	206
2015 Q1	$16K	Buy	+144	New	+$16.4K	0.01%	222

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

US Financial Advisors's ZBH Position: Q1 2016 in Review

US Financial Advisors sold out of Zimmer Biomet (ZBH) in Q1 2016, closing a stake of 144 shares — an estimated $14K sold.

US Financial Advisors first reported a position in ZBH in Q1 2015 and held it in 4 quarters. The position peaked at $16K in Q1 2015. 746 funds tracked by Wall St. Rank hold ZBH as of Q1 2016.

US Financial Advisors reported no remaining Zimmer Biomet position as of Q1 2016 after selling out during the quarter.
US Financial Advisors sold 144 Zimmer Biomet shares in Q1 2016, an estimated $14K.
US Financial Advisors first reported a position in Zimmer Biomet in Q1 2015 and held it in 4 quarters.
US Financial Advisors's Zimmer Biomet position peaked at $16K in Q1 2015.
746 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2016.

Based on US Financial Advisors's 13F filing for Q1 2016, filed 5 May 2016.